Form 4: IGM Biosciences Director Acquires Shares Through Restricted Stock Units

Director Christina Teng Topsoe acquired shares of IGM Biosciences through vested restricted stock units, according to a recent SEC filing.

Summary

• Christina Teng Topsoe, a director of IGM Biosciences, acquired 2,687 shares of common stock on December 31, 2024, through fully vested restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of IGM Biosciences' common stock each.
• The acquisition was part of a quarterly retainer paid in common stock under the company's Outside Director Compensation Policy.
• Vested RSUs will be delivered upon a change in control of IGM Biosciences or the director's retirement/separation.
• Topsoe also has indirect ownership of 10,400,564 shares through Topsoe Holding A/S and 9,800 shares through Pillarcater LLC.
• Topsoe disclaims beneficial ownership of the shares held by Topsoe Holding A/S except to the extent of her pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's compensation in the form of stock. It doesn't inherently suggest positive or negative implications for the company's performance.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

Vested RSUs will be delivered to the Reporting Person on the earlier of (i) immediately prior to a change in control of the Issuer or (ii) following the Reporting Person's retirement or separation from service with the Issuer.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.

Key Dates